Daiichi Sankyo Bags US$6.9 Billion AstraZeneca Pact for Cancer Hopeful DS-8201, Announces CEO Change

April 1, 2019
Daiichi Sankyo Chairman & CEO Joji Nakayama Speaks at Tokyo Press Conference on March 29 Daiichi Sankyo won a big ally for its bold ambition to morph into an oncology powerhouse, with AstraZeneca agreeing to pay up to US$6.9 billion...read more